Expression of Hepatitis C Virus cDNA in Human Hepatoma Cell Line Mediated by a Hybrid Baculovirus–HCV Vector  by Fipaldini, Cristina et al.
a
p
n
e
s
i
a
T
o
a
a
g
p
b
p
h
X
H
l
N
E
1
R
d
F
Virology 255, 302–311 (1999)
Article ID viro.1998.9565, available online at http://www.idealibrary.com on
0
C
AExpression of Hepatitis C Virus cDNA in Human Hepatoma Cell Line Mediated
by a Hybrid Baculovirus–HCV Vector
Cristina Fipaldini, Barbara Bellei, and Nicola La Monica1
IRBM “P. Angeletti,” Pomezia 00040, Italy
Received September 17, 1998; returned to author for revision October 12, 1998; accepted December 9, 1998
Although great progress has been made in the characterization of the biochemical and biological features of hepatitis C
virus (HCV) gene expression, the elucidation of the HCV life cycle and the evaluation of novel antiviral strategies have been
hindered by the lack of a suitable cell culture system. In this context, the development of an efficient HCV cDNA delivery
method would contribute to the understanding of HCV replication. To assess the functionality of baculovirus mediated gene
delivery for HCV expression, we have constructed recombinant baculoviruses encoding HCV cDNA under the control of the
cytomegalovirus promoter. Transduction of the human hepatoma cell line Huh-7 with Bac–HCV vectors was efficient and HCV
cDNA expression was enhanced by treatment of the infected cells with dexamethasone. HCV structural and nonstructural
polypeptides were processed correctly and were found to localize in the cytoplasm in a pattern characteristic of the
endoplasmic reticulum. The expression of the HCV proteins was detected for 49 days after infection. Thus, these results
indicate that the recombinant Bac–HCV vectors are a useful tool for the delivery of HCV cDNA and can facilitate the analysis
of structural and functional properties of the HCV proteins. In addition, the Bac–HCV vectors can provide important
information on the evaluation of novel anti-HCV antiviral strategies. © 1999 Academic Press
t
v
f
e
s
p
1
p
t
(
n
h
v
(
c
d
a
p
c
v
a
s
p
b
o
a
p
pINTRODUCTION
Hepatitis C virus (HCV) is a member of the Flaviviridae
nd it is now recognized as the major cause of both
arenterally transmitted and community-acquired non-A
on-B hepatitis (Choo et al., 1989; Kuo et al., 1989). The
nveloped virion contains a single-stranded positive-
ense RNA genome of about 9600 nucleotides consist-
ng of a 59 nontranslated region (NTR) that functions as
n internal ribosome entry site (Fukushi et al., 1994;
sukiyama-Koharak et al., 1992; Wang et al., 1993), a long
pen reading frame (ORF) encoding a polyprotein of
pproximately 3000 amino acids, and a 39 NTR (Choo et
l., 1991; Kato et al., 1990; Takamizawa et al., 1991). The
enome RNA was originally thought to terminate with
olyadenylate [poly(A)] or polyuridylate [poly(U)] tracts,
ut recent studies revealed the presence of an internal
oly(U)/polypyrimidine ([poly(U/UC)] tract followed by a
ighly conserved 98-nucleotide sequence termed the
-tail (Kolykhalov et al., 1996; Tanaka et al., 1995). The
CV ORF encodes a polyprotein precursor with the fol-
owing gene order: NH2 C-E1-E2-p7-NS2-NS3-NS4a-
S4b-NS5a-NS5b COOH (Bartenschlager et al., 1993;
ckart et al., 1993; Grakoui et al., 1993a, b; Hijikata et al.,
993a, b; Lin et al., 1994a, b; Tomei et al., 1993). C is an
NA binding protein (Santolini et al., 1994) believed to be
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302he viral nucleocapsid, E1 and E2 are thought to be the
irion glycoproteins, and p7 is a protein of unknown
unction inefficiently cleaved from the E2 polypeptide (Lin
t al., 1994a; Mizushima et al., 1994). Processing of the
tructural polypeptides is mediated by cellular signal
eptidase of the endoplasmic reticulum (Hijikata et al.,
993b; Santolini et al., 1994). The NS2–NS5B proteins are
utative nonstructural proteins involved in processing of
he polyprotein precursor and viral RNA replication
Clarke, 1997). Although properties of the HCV-encoded
onstructural proteins such as serine proteinase, RNA
elicase, and polymerase as well as the mechanism of
iral protein processing have been extensively studied
Nedderman et al., 1997), and infectious RNA transcripts
apable of causing disease in chimpanzees have been
escribed (Kolykhalov et al., 1997; Yanagi et al., 1997),
nd detailed analysis of viral replication has been ham-
ered by the inability to efficiently propagate the virus in
ultured cells. This limitation is of particular relevance in
iew of the lack of an effective treatment of HCV infection
nd of an urgent need for a vaccine to prevent HCV
pread in humans.
Most of the information available on the proteins ex-
ressed by the HCV genome has been obtained to date
y comparative analysis of its genomic sequence with
ther known viruses, as well as from analysis of in vitro
nd ex vivo systems expressing cloned viral cDNA. In
articular, the expression and processing of HCV
olyprotein have been extensively studied ex vivo usingecombinant vaccinia virus expressing the T7 RNA poly-
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303EXPRESSION OF HCV cDNA IN HUMAN HEPATOMA CELL LINEerase (VacT7) (Fuerst et al., 1986). The VacT7 drives the
ranscription of transfected plasmids that carry the HCV
DNA inserted downstream of a T7 promoter. Although
he VacT7 virus offers an efficient and useful mammalian
ransient-expression system, the extensive cytopathic ef-
ect (CPE) caused by vaccinia virus can interfere with the
nalysis of the expressed products and limits the time in
hich the intracellular fate and biochemical features of
hese proteins can be studied. Alternatively, cell lines
xpressing parts of or the entire HCV cDNA that could be
sed to assess some of the biological features of HCV
roteins have been described, although the expression
evel has been in most cases quite low, whereas a high
evel of expression of the HCV polypeptides has been
ound to be toxic to the cells (Harada et al., 1995a, b;
oradpour et al., 1996, 1998).
Recently, the use of Autographa californica multiple
uclear polyhedrosis virus (AcNPV) as a vector for deliv-
ry of genes in mammalian cells has been reported
Hofmann et al., 1995; Boyce and Bucher, 1996). Although
he baculovirus expression system has normally been
sed for production of a wide variety of foreign genes
ecause of its high level of expression in insect cells
Miller, 1993), AcNPV was shown to infect human hepa-
ocytes and fibroblasts, leading to an efficient transient
xpression of reporter genes under the control of an
ppropriate mammalian promoter. Additionally, infection
f cultured cell lines with recombinant baculoviruses
oes not cause any CPE even at a high multiplicity of
nfection (m.o.i.) (Sandig et al., 1996). Finally, the inclu-
ion of the vesicular stomatitis virus G glycoprotein en-
ances the efficiency of transduction of human hepato-
ytes and broadens the range of mammalian cells types
hat can be transduced by baculovirus (Barsoum et al.,
997). Thus, the use of recombinant baculoviruses may
llow monitoring the long-term ex vivo expression of
ransduced genes in a variety of cell types without per-
urbing the physiological state of the infected cells. In
his report, we have characterized the expression of HCV
DNA in human hepatoma cells mediated by baculovirus
ectors carrying the HCV cDNA under the control of the
ytomegalovirus (CMV) promoter. Results show that bac-
lovirus mediated expression of the full-length HCV
DNA is efficient and leads to the production of properly
rocessed HCV proteins that can be monitored for a
rolonged period of time.
RESULTS
onstruction of recombinant Bac–HCV vectors
To exploit the high efficiency of baculovirus mediated
ene transfer in mammalian cells for the transduction of
CV cDNA, a series of recombinant baculovirus vectors
as constructed. Figure 1A shows the vectors used in
his study. In all constructs the HCV cDNA was cloned
ownstream of a CMV immediate early promoter. To tinimize the presence of additional sequence at its 59
nd, the HCV cDNA was cloned so that its first nucleo-
ide was inserted at the corresponding transcription ini-
iation site of the CMV promoter. Furthermore, to ensure
hat the HCV transcripts did not include any additional
equence derived from the baculovirus genome, the HDV
ntigenomic ribozyme was inserted at the 39 end of the
CV cDNA (Fig. 1B). The HDV ribozyme has been suc-
essfully used to generate viral genomic transcripts with
he correct 39 and (Ball, 1994; Ball and Li, 1993; Pattnaik
t al., 1992). The functionality of the HDV antigenomic
ibozyme was assessed on in vitro synthesized tran-
cripts (data not shown). Bac-9.4 carries the HCV-BK
DNA extending from nucleotide (nt) 1 to 9416. In con-
rast, Bac-9.6 carries the same HCV cDNA in which the
ecently described 39 NTR of the viral RNA was included
Kolykhalov et al., 1996; Tanaka et al., 1995). As control,
ac-DOF was also constructed by introducing a deletion
f nt 699 to 1907. This deletion abolishes the correct
ranslation of the remaining part of the HCV ORF (see
elow). Finally, baculovirus carrying the CMV–b-Gal
Bac–b-Gal) (Palombo et al., 1998) was also used in this
tudy as a control for transduction efficiency. Viruses
ere produced at high titers ranging from 5 3 108 to 1 3
09 PFU/ml and the structure of the baculoviruses
enomic DNA was confirmed by Southern blot analysis
data not shown). Taken together, these results indicate
hat the Bac–HCV vectors can be produced to high titers
nd that no rearrangement of the HCV cDNA had oc-
urred upon rescue and amplification.
ransduction of human hepatoma cell line Huh-7
The recombinant Bac–HCV vectors were used to
ransduce human hepatoma cell line Huh-7. This cell line
as been shown to be susceptible to baculovirus trans-
uction (Hoffman et al., 1995). The efficiency of transduc-
ion of the Bac–HCV was monitored by indirect immuno-
luorescence assay using a rabbit antiserum specific for
he NS5A protein (see below; Tomei et al., unpublished
esults). As control, Huh-7 cells were also infected with
ac–b-Gal vector and the transduction of the infected
ells was assessed by monitoring b-Gal activity. Table 1
hows the efficiency of transduction of Huh-7 cells in-
ected with Bac-9.4 at a m.o.i. of 100 and 1000 at 48 h p.i.;
.6% of the Huh-7 cells infected with Bac-9.4 at a m.o.i. of
00 were detected by the anti-NS5A antiserum, whereas
0.6% of the cells infected at a m.o.i. of 1000 were
ositive for HCV protein expression. In an attempt to
ncrease the number of cells transduced by the recom-
inant baculovirus the Huh-7 cells were treated with 1
M dexamethasone at the time of infection. Dexameth-
sone treatment has been shown to enhance and pro-
ong gene expression in both primary hepatocytes and
iver cells (Malone et al., 1994). The number of cells
ransduced by Bac-9.4 increased to 6.8% at a m.o.i. of 100
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304 FIPALDINI, BELLEI, AND LA MONICAnd to 27.3% at a m.o.i. of 1000. A similar increase in
ransduction was observed with vector Bac-9.6 (data not
hown). The increase in transduction efficiency medi-
ted by dexamethasone was not limited to the Bac–HCV
ectors but was also observed upon infection with Bac–
-Gal. In fact, a twofold increase in b-Gal expression
as detected in infected cells after dexamethasone
reatment. The transduction efficiency of recombinant
aculovirus vectors appeared to be better than that ob-
FIG. 1. Schematic representation of the HCV genome, protein coding d
s shown at the top (thin line, untranslated regions; open box, open rea
hown. The name of each vector is shown on the left. The deletion of nuc
egulating expression of HCV and b-Gal is shown on the left. The hatc
he vector Bac–b-Gal (Palombo et al., 1998) is also shown. (B) The jun
he HindIII site, and the HCV nucleotides are indicated in capital letters
umber related to the HCV genome is also shown. (C) The 39 end seq
n capital letters, and the HDV antigenomic ribozyme is also indicated. B
aterials and Methods.ained by lipofection of plasmid DNA. In fact, a two- to phreefold difference in the percentage of transduced
uh-7 cells was observed when the transduction effi-
iency of Bac–b-Gal was compared to that obtained by
ransfection of the pFB–b-Gal shuttle plasmid. Thus,
hese results indicate Bac–HCV vectors can transduce
he human hepatoma Huh-7 and that dexamethasone
reatment of infected cells contributes to an increase in
ransduction efficiency.
To verify that the entire HCV polyprotein was ex-
s, and recombinant baculoviruses used in this study. The HCV genome
ame). (A) The recombinant baculoviruses carrying the HCV cDNA are
s 699 to 1907 in Bac-DOF is indicated by a thin line. The CMV promoter
x representing the HDV antigenomic ribozyme is shown on the right.
etween the CMV promoter and HCV cDNA is shown. The TATAA box,
ranscription initiation site is indicated by an arrow, and the nucleotide
of the Bac–HCV vectors. The 39 sequence of the HCV cDNA is shown
rus transfer plasmids were derived from pFastBac1 as described underomain
ding fr
leotide
hed bo
ction b
. The t
uence
aculoviressed upon infection, the Huh-7 cells were subjected
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305EXPRESSION OF HCV cDNA IN HUMAN HEPATOMA CELL LINEo immunofluorescence analysis using a panel of rabbit
ntisera specific for individual HCV proteins. Figure 2
hows that the HCV proteins Core (Fig. 2A), E2 (Fig. 2B),
S3 (Fig. 2C), NS4 (Fig. 2D), and NS5A (Fig. 2E) were
xpressed in the transduced cells. As shown in Fig. 2F,
he infected cells showed a variation in the fluorescence
ntensity, suggesting that the infection efficiency and
ubsequent expression of the HCV polyprotein were not
omogeneous within the same culture. The expressed
CV proteins were localized exclusively within the cyto-
lasm of the infected cells with characteristic reticular
taining. However, perinuclear staining of the trans-
uced cells could also be detected, whereas no staining
as observed with mock infected cells (data not shown).
similar overall labeling pattern has been observed in
ransfected cells with a variety of plasmids encoding
arts of or the entire HCV cDNA (Santolini et al., 1994;
elby et al., 1993).
The correct processing of the HCV polyprotein was
ssessed by performing Western blot as well as immu-
oprecipitation analysis of infected cell lysates. As
hown in Fig. 3, proteins of 68 kDa (lane 2), 56–58 kDa
lane 4), and 65 kDa (lane 6) corresponding to NS3,
S5A, and NS5B, respectively, were detected in the Bac-
.4 infected cells. The two bands detected by the anti-
S5A antiserum probably correspond to the phosphory-
ated forms of this HCV polypeptide (Kaneko et al., 1994).
imilarly, proteins of molecular mass of 61 kDa (Fig. 3,
ane 8) and 21 kDa (Fig. 3, lane 10) corresponding to the
2 and NS2 polypeptides, respectively, were immunopre-
TABLE 1
Dexamethasone Enhancement of Baculovirus
Mediated Gene Expressiona
HCV positive cellsb
Virus M.O.I. 2 Dex 1 DEX
ac-9.4 100 33/1260 (2.6%) 78/1134 (6.8%)
1000 15/142 (10.6%) 69/252 (27.3%)
b-Gal Activityc
2Dex 1Dex
ac–b-Gal 100 0.239 0.561 (2.3)
a Huh-7 cells were infected in duplicate with recombinant baculovi-
us vectors and incubated either with or without dexamethasone. The
xpression of the transduced genes was assayed at 48 h.
b Expression of HCV cDNA in infected Huh-7 cells was assessed by
ndirect immunofluorescence assay using anti-NS5A rabbit polyclonal
ntiserum. The number of fluorescent cells over the total number of
ells analyzed is reported. Number in parentheses indicates the per-
entage of positive cells.
c b-Gal expression was measured by enzymatic assay using whole
ell lysates. Values reported refer to OD450 per 5 mg of whole cell
xtract. Number in parentheses indicates the dexamethasone en-
ancement of expression.ipitated with specific anti-HCV antisera. No HCV pro- neins could be detected in cells infected with Bac-DOF
Fig. 3, lanes 1, 3, 5, 7, and 9) or in mock infected cells
data not shown). Taken together, these results indicate
hat the HCV cDNA expression mediated by the Bac–
CV vectors results in the correct processing and cellu-
ar localization of the HCV polypeptides.
ersistent expression of the HCV cDNA
To investigate the stability of the baculovirus trans-
erred HCV cDNA, we examined the duration of HCV
rotein expression in cells infected with Bac-9.4 and
reated with dexamethasone. Additionally, to verify
hether the structure of the HCV RNA could influence
he persistence of expression, Huh-7 cells were also
nfected with Bac-9.6. The expression of the HCV cDNA
as detected by immunofluorescence analysis using the
nti-NS5A antiserum after infection of hepatoma cells
ith recombinant baculoviruses Bac-9.4 and Bac-9.6.
S5A was detected for a period of 49 days, although the
verall percentage of transduced cells progressively de-
reased upon passage over two orders of magnitude. No
ifferences in the kinetics of expression was noted be-
ween the Bac-9.4 and the Bac-9.6 infected Huh-7 cells,
hereas no expression of the HCV proteins was de-
ected in mock infected cells over the whole period of
ime measured (Fig. 4). Long-term expression of HCV
roteins in cells infected with Bac-9.4 or Bac-9.6 was not
imited to NS5A, but included other HCV polypeptides
uch as NS3 (Fig. 5A) and NS4 (Fig. 5B) that could be
etected 38 days p.i., roughly with the same frequency
s NS5A.
To verify whether the Bac–HCV vectors displayed the
ame RNA stability, RNase protection analysis was per-
ormed on Bac-9.4 and Bac-9.6 infected Huh-7 cell RNA
nd compared to that of RNA extracted from Bac-DOF
nfected cells. Total RNA harvested from cells at 4, 7, and
1 days p.i. was subjected to a stringent hybridization
rocedure with a 32P-labeled RNA probe of 264 nt com-
lementary to nt 6000–6210 of HCV that corresponds to
he NS4 coding region. Single-stranded RNA was hydro-
yzed by exposing the hybridization reaction to a mixture
f RNase A and RNase T1 and the double-stranded
rotected probe was subsequently analyzed by electro-
horesis on a denaturing polyacrylamide gel and then by
utoradiography. As shown in Fig. 6, a 210-nt band,
orresponding to the protected portion of the labeled
robe, was detected in the infected cell RNA samples, at
days p.i. (lanes 7 to 9). No differences were noted in the
evels of HCV RNA present in the cells infected with the
hree vectors since the intensity of the protected band
rogressively decreased at 7 and 11 days p.i. in all
amples (lanes 10 to 17). The probe was specific for HCV
NA of positive polarity detecting 100 pg of in vitro
ranscribed positive-sense RNA (lanes 3 to 5), whereas
o protection could be detected upon hybridization with
m
n
i
s
t
t
e
r
t
t
p
f
w
(
a
b
k
V
o
b
s
g
t
m
(
w
306 FIPALDINI, BELLEI, AND LA MONICAock infected RNA (lane 6) or with in vitro transcribed
egative-sense HCV RNA (lane 2). Thus, these findings
ndicate that infection of Huh-7 cells with Bac–HCV re-
ults in prolonged expression of the HCV proteins and
hat no apparent differences in the stability of the HCV
ranscripts could be ascribed to the RNA structure or the
xpression of HCV polypeptides.
DISCUSSION
In this study, we have developed a chimeric baculovi-
us–HCV virus with which the HCV cDNA can be easily
ransduced into mammalian cells and the persistence of
he HCV expression can be monitored for a prolonged
FIG. 2. Indirect immunofluorescence analysis of cells expressing HCV
ade permeable. Staining of infected cells was performed as described
A), E2 (B), NS3 (C), NS4B (D), and NS5A (E). A low magnification of infe
as tetramethyl rhodamine isocyanante-conjugated goat anti-rabbit imeriod of time. pBaculovirus was chosen as vector for the gene trans-
er of HCV cDNA because of its capacity to transduce
ith high efficiency primary human and rat hepatocytes
Boyce and Bucher, 1996; Hofmann et al., 1995) as well
s numerous stable cell lines such as rat primary fibro-
lasts, human fibroblast strain MRC-5, human embryonic
idney cell strain 293 (Palombo et al., 1998), CV-1, Cos7,
ero, and HeLa cells (Yap et al., 1997). Additionally, we
bserved that Bac–HCV vectors grow to titers compara-
le to those of other recombinant baculoviruses (data not
hown) without any apparent rearrangement of their
enomic structure. Thus, the lack of size limitation of the
ransferred gene (O’Reilly et al., 1992), and the ease of
ns. Huh-7 cells were infected with Bac-9.4 and 48 h p.i. were fixed and
lini et al., 1994) using rabbit polyclonal antisera directed against Core
lls stained with anti-NS5A antibody is shown in F. Secondary antibody
lobulin G.protei
(Santo
cted ce
munogroduction to high virus titers render this vector an ideal
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307EXPRESSION OF HCV cDNA IN HUMAN HEPATOMA CELL LINEehicle with which to monitor the expression of the HCV
DNA in a variety of cell lines. This conclusion is in
greement with the data published by Shoji et al. (1997)
escribing the expression of the HCV Core protein in
ammalian cells mediated by a baculovirus vector.
The transduction efficiency of the recombinant bacu-
ovirus vectors was enhanced by treatment of the cell
ulture with dexamethasone (Table 1). Although we have
ot analyzed in detail the effects of dexamethasone on
ranslation efficiency of HCV RNA or on protein stability,
t is likely that the effect on gene expression mediated by
examethasone is due to indirect induction of CMV pro-
oter, perhaps by increasing synthesis of cellular factors
hat interact with CMV regulatory elements (West et al.,
FIG. 3. Expression of HCV proteins in baculovirus infected cells.
uh-7 cells were infected with Bac-9.4 (lanes 2, 4, 6, 8, and 10) or
ac-DOF (lanes 1, 3, 5, 7, and 9) and processed for Western blot
nalysis (lanes 1 to 6) or for immunoprecipitation studies (lanes 7 to 10)
ith HCV-specific antibodies as described under Materials and Meth-
ds. The position of molecular size standards (in kilodaltons) is indi-
ated.
FIG. 4. Kinetics of Bac–HCV expression. Huh-7 cells were infected
ith Bac-9.4 and Bac-9.6 and expression of the HCV cDNA was deter-
ined at time points indicated by indirect immunofluorescence withenti-NS5A antiserum. The percentage of transduced cells is reported.988). The effect of dexamethasone on the CMV pro-
oter has in fact been reported (Malone et al., 1994), and
t is also supported by the observation that cells trans-
uced with Bac–b-Gal show a twofold induction in b-Gal
ctivity upon dexamethasone treatment.
We have shown that the cellular and viral proteolytic
achineries involved in the processing of the HCV
olypeptides are functional upon infection of the Huh-7
ells with Bac–HCV vectors. Both the size and the cellu-
ar localization of the viral proteins match the data ob-
ained in cell-free translation and transient transfection
tudies (Figs. 2 and 3). Interestingly, the NS5B protein
as readily detected in infected cells (Fig. 3). The detec-
ion of the putative viral replicase in Huh-7 cells differs
rom what has been reported with human cell lines
nducibly expressing the structural and nonstructural
roteins where NS5B could not be detected (Moradpour
FIG. 5. Long-term expression of HCV proteins in infected cells. Huh-7
ells were infected with Bac-9.6 and expression of the HCV cDNA was
etermined 38 days p.i. by indirect immunofluorescence with (A) anti-
S3 and (B) anti-NS-4 rabbit antisera. Staining of infected cells was
erformed as described (Santolini et al., 1994).t al., 1998). Although we have not examined the half-life
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308 FIPALDINI, BELLEI, AND LA MONICAf the NS5B protein in infected Huh-7 cells, it is possible
hat the greater stability of the NS5B encoded by the BK
train may be ascribed to the sequence of this particular
lone (Takamizawa et al., 1991). Alternatively, the human
epatoma cell line may have contributed, at least in part,
o the stabilization of the NS5B polypeptide. We are
urrently examining the expression of HCV proteins me-
iated by baculovirus in different cell lines.
Processing of the HCV nonstructural polypeptides is
ediated by the NS3 serine protease and by the NS2/3
utoprotease (Clarke, 1997). Both viral enzymes are func-
ional upon Bac–HCV infection of Huh-7 cells as indi-
ated by the detection of processed NS2, NS3, NS4,
S5A, and NS5B. In view of the observation that viral
roteases play a pivotal role in the life cycle of viruses
uch as bovine diarrhea virus and yellow fever virus
Chambers et al., 1990; Xu et al., 1997) that are related to
CV, the NS3 serine protease has become a major target
or the development of novel antiviral agents. Infection of
uman hepatoma cells with Bac–HCV may, therefore,
rovide an ideal system with which to test for the inhib-
tory effects of new compounds in a well-defined cellular
ontext.
The cellular localization of HCV proteins Core, E2,
S3, NS4, and NS5A was assessed by indirect immun-
fluoroescence and these polypeptides were found in
he cytoplasm in a reticular staining characteristic of the
R. No nuclear localization of the viral protein was de-
ected in the infected cells, even after prolonged passag-
ng of the cell culture. Therefore, it is very likely that the
R may be the site of both membrane-associated RNA
eplication and assembly. Additionally, because Bac–
CV expression in transduced cells could be detected
or 49 days without any apparent toxic effect (Figs. 4 and
FIG. 6. HCV RNA analysis in Bac–HCV infected cells. Huh-7 cells
ere infected with Bac-9.4 (lanes 8, 11, and 14), Bac-9.6 (lanes 7, 10, and
3), and Bac-DOF (lanes 9, 12, and 15) and cells were kept in culture
nd passaged for an extended period of time. At the indicated times
otal RNA was harvested from infected cells and RNase protection
nalysis was carried out as described under Materials and Methods
sing a 264-nt probe complementary to nt 6000–6210 of HCV (lane 1).
s control, the probe was hybridized to in vitro transcribed negative-
ense RNA (lane 2) and to 100 ng (lane 3), 10 ng (lane 4), and 0.1 ng
lane 5) of in vitro transcribed positive-sense RNA and to RNA extracted
rom mock infected cells (lane 6). The size of the protected portion of
he radiolabeled probe is indicated.), the use of a Bac–HCV infection system may allow the wtudy of the cellular and viral requirements for HCV
orphogenesis. To this end, we are currently performing
lectron microscopy studies on infected cells to verify
rotein assembly and HCV particle formation.
The stability of the HCV RNA transcribed from the
arious Bac–HCV vectors did not seem to differ, suggest-
ng that neither RNA structure nor protein expression
ffected the persistence of the transcribed HCV RNA
Fig. 6). In addition, no sign of HCV replication could be
etected either by RNase protection analysis or by PCR
mplification of negative-sense RNA (data not shown).
lthough it is possible that cellular factors required for
CV replication are not present in Huh-7 cells, it is likely
hat the cDNA utilized in the construction of Bac–HCV
ectors is not infectious.
The demonstration that RNA transcribed from cloned
CV cDNA can initiate infection and cause hepatitis in
ransfected chimpanzees (Kolykhalov et al., 1997; Yanagi
t al., 1997) indicates that the correct clone of HCV
enome is now available to identify and optimize appro-
riate cell culture conditions for HCV replication studies.
owever, this effort will require an efficient gene delivery
rotocol. In this context, the use of baculovirus to medi-
te gene transfer on cultured cell lines as well as in ex
ivo perfused liver tissue (Sandig et al., 1996) can con-
ribute to the identification of the cell culture conditions
uitable for HCV replication.
MATERIALS AND METHODS
ector constructs
Recombinant baculoviruses carrying the HCV cDNA
ere constructed by using the transfer vector pFastBac1
Gibco BRL). pFastBac1 was modified by deleting the
olyhedrin promoter sequence by digestion with SnaBI
nd BamHI and ligated with the HCV expression cas-
ettes. The SnaBI and BamHI sites were blunt-ended
ith Klenow fragment before ligation. The HCV-BK cDNA
Takamizawa et al., 1991) used for the construction of
ecombinant baculoviruses is derived from plasmid
CD(38-9.4) (Tomei et al., 1993). Prior to being cloned into
he transfer vector pFastBac1, the HCV cDNA was mod-
fied by adding the nucleotides GCCAGCCCC at its 59
TR, flanked at its 59 end by a HindIII restriction site.
his sequence was defined as nt 1 to 9 of the HCV
enome. The HCV cDNA was cloned downstream of a
MV immediate early promoter that was engineered to
arry a HindIII restriction site and m.o.i. such that nucle-
tide 1 of HCV was positioned at the CMV transcriptional
nitiation site (S. Colloca, unpublished results). Similarly,
he hepatitis delta virus (HDV) antigenomic ribozyme was
dded downstream of the 39 NTR. The HDV antigenomic
ibozyme fragment was generated by primer extension of
equence-specific primers and cloned in the XbaI and
acI sites (Perrotta and Been, 1991). All modifications
ere carried out using sequence-specific primers ac-
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erived plasmids were constructed: pFB(9.4), pFB(9.6),
nd pFB(DOF).
Bac-9.4 contains the HCV sequence from nt 1 to 9416
nserted between the CMV promoter and the HDV anti-
enomic ribozyme sequence. Bac-9.6 contains the full-
ength HCV genome from nt 1 to 9622. The 39 X tail was
enerated by primer extension of sequence-specific
rimers and inserted by blunt-end ligation in the XbaI
ite, between the poly(U) tail and the HDV antigenomic
ibozyme in Bac-9.4. Bac-DOF was derived from Bac-9.6
y deleting the sequence nt 699–1907 by digestion with
laI and SnaBI. This deletion determines a frameshift of
he HCV ORF.
Bac–b-Gal contains the b-galactosidase gene under
he control of the CMV promoter, as previously described
Palombo et al., 1998). Recombinant baculoviruses were
enerated according to the manufacturer’s instructions
Gibco BRL). Budded virus from insect cell culture me-
ium was filtered through a 0.22-mm (pore size) filter and
oncentrated by ultracentrifugation in a 45 It rotor (30,000
pm, 75 min). The viral pellets were resuspended in
hosphate-buffered saline (PBS) and infectious titers
ere determined by plaque assay on Sf9 cells. Baculo-
irus genomic DNA was prepared from 1 ml of the third
iral passage according to standard protocols (O’Reilly et
l., 1992). The genomic structure of the recombinant
aculoviruses was examined by Southern blot analysis
s previously described (Palombo et al., 1998).
ell culture
Huh-7 cells were maintained in Dulbecco’s modified
agle’s medium (DMEM) supplemented with 10% fetal
alf serum (FCS). Unless specified otherwise, cell mono-
ayers were routinely infected at a m.o.i. of 1000. Six
ours prior to infection, cells were plated at a density of
3 106 cells/plate in 10-cm plates. The baculovirus
noculum was diluted in 3 ml of DMEM containing 10%
eat-inactivated fetal bovine serum and added to cells.
fter 1 h at 37°C, the viral inoculum was replaced by
resh medium. Where indicated, the medium was sup-
lemented with 1 mM dexamethasone. The infected cell
ultures were maintained for the indicated time. When
he monolayers reach confluency, cells were split 1:4 and
eplated.
mmunofluorescence analysis
Infected Huh-7 cells were grown on glass coverslips
ntil confluence and fixed with cold methanol for 4 min at
20°C. Fixed cells were washed with PBS and incu-
ated with rabbit polyclonal antibodies raised against
ingle HCV proteins (Tomei et al., 1993) as previously
escribed (Santolini et al., 1994). Coverslips were
ounted in Moviol and photographed with rhodamine Bilter on a Leica Diaplan photomicroscope with a 25X
lanar objective.
estern blot analysis
Forty-eight hours p.i. Huh-7 cells were collected,
ashed with PBS, and lysed by freezing and thawing
hree times in 0.25 M Tris–HCl, pH 7.5. Fifty micrograms
f protein extract was resolved by sodium dodecyl sul-
ate–10% polyacrylamide gel electrophoresis and then
ransferred onto a nitrocellulose membrane. The mem-
rane was incubated with anti-HCV rabbit antiserum
iluted in the blocking buffer containing 5% skimmed
ilk, 10 mM Tris–HCl (pH 8), 150 mM NaCl, 0.05% Tween
0 for 12 h at 4°C. The membrane was washed with
locking buffer and then incubated with AP-conjugated
econdary antibody for 1 h at room temperature as pre-
iously described (Esposito et al., 1995).
mmunoprecipitation assay
Forty-four hours p.i. the medium was replaced with
EM lacking methionine (Gibco) and the infected cells
ere incubated for 1 h at 37°C. Cells were then radio-
abeled for 4 h with 35S label (ICN) in 3 ml of MEM
acking methionine and supplemented with 10% dialyzed
CS. Infected cells were harvested and cell lysates were
ncubated with anti-HCV-specific rabbit polyclonal anti-
erum and processed as previously described (Tomei et
l., 1993).
Nase protection assay
Infected cells were harvested at the indicated time
nd total RNA was extracted from 1 3 106 cells using the
ltraspek lysis buffer (Biotecx Lab. Inc.) according to the
anufacturer’s specifications. The extracted RNA was
reated for 4 h at 37°C with RNase-free DNase and
ubsequently with 200 mg Proteinase K for 1 h at 30°C.
he RNA solution was mixed with 1 vol of GIT buffer (4 M
uanidine isothiocyanate, 0.1 M sodium acetate, pH 5.5,
mM EDTA, 0.5% Sarkosyl, 0.1 M b-mercaptoethanol)
nd precipitated with 2 vol of isopropanol. The pelleted
NA was resuspended in 20 ml of hybridization buffer
80% formamide, 100 mM sodium citrate, 300 mM sodium
cetate, 1 mM EDTA) and subjected to hybridization with
32P-labeled RNA probe specific for positive-sense HCV
NA. Hybridization and RNase A and RNase T1 digestion
onditions were as described (Novak and Kirkegaard,
991). As control, in vitro transcribed positive- and neg-
tive-sense RNA derived from plasmid pCD(38-9.4) was
lso subjected to hybridization and RNase digestion pro-
ocol. The digested RNA samples were analyzed elec-
rophoretically on a 6% polyacrylamide/7 M urea gel.
-galactosidase assay
Huh-7 cells (1 3 105) were infected with recombinant
ac–b-Gal at a m.o.i. of 100. Forty-eight hours later, cells
w
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310 FIPALDINI, BELLEI, AND LA MONICAere collected, washed with PBS, and lysed by freezing
nd thawing three times in 0.25 M Tris–HCl, pH 7.5. The
ssay for b-galactosidase activity was carried out with 5
g of whole cell lysate using the Promega kit as de-
cribed by the manufacturer.
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